GPX4 and melanoma: This ferroptotic resistance was even more prominent when melanoma cells were treated with RSL3 (RAS‐selective lethal), a drug that induces ferroptosis by inhibiting the glutathione peroxidase 4 (GPX4) (Jiang et al, 2021) (Figs 7L and EV5C).